Answers are grounded in this paper and cite their sources.
Evidence shows that economic, social, awareness, healthcare system, and cultural barriers significantly impact patient access to long-acting injectable HIV prevention methods. Addressing these barriers through policy, awareness, and systemic improvements can enhance uptake and equity in access.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: